NASDAQ: PTIX
Protagenic Therapeutics Inc Stock Ownership - Who owns Protagenic Therapeutics?

Insider buying vs selling

Have Protagenic Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PTIX insiders and whales buy or sell their stock.

PTIX Shareholders

What type of owners hold Protagenic Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alexander K. Arrow2.39%45,815$136.53kInsider
Osaic Holdings Inc1.12%21,414$63.81kInstitution
Virtu Financial LLC0.98%18,808$56.05kInstitution
Alpine Global Management LLC0.85%16,351$48.73kInstitution
Morgan Stanley0.78%15,002$44.71kInstitution
Susquehanna International Group LLP0.53%10,156$30.26kInstitution
Ubs Group Ag0.47%9,020$26.88kInstitution
Barrett Evans0.34%6,498$19.36kInsider
Tower Research Capital LLC Trc0.05%876$2.61kInstitution
Citigroup Inc0.02%390$1.16kInstitution

1 of 2

PTIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTIX3.69%2.73%
CMND10.96%0.00%
KTTA2.86%97.14%Net Selling
SILO4.33%2.16%Net Buying
CANF0.02%0.00%

Protagenic Therapeutics Stock Ownership FAQ

Who owns Protagenic Therapeutics?

Protagenic Therapeutics (NASDAQ: PTIX) is owned by 3.69% institutional shareholders, 2.73% Protagenic Therapeutics insiders, and 93.58% retail investors. Alexander K. Arrow is the largest individual Protagenic Therapeutics shareholder, owning 45,815.00 shares representing 2.39% of the company. Alexander K. Arrow's Protagenic Therapeutics shares are currently valued at $126.45k.

If you're new to stock investing, here's how to buy Protagenic Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.